RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Skyviews Life Science
S

Skyviews Life Science portfolio

Skyviews Life Science has 3 portfolio companies on record at Recent Funding. Its most recent investment on record is Tropic Biosciences's $35M Series B+ round in July 2022, alongside Tekfen Ventures, Sucden Ventures, Rage Capital and 4 others. By category, its portfolio leans toward Commerce and retail (2) and Health and bio (2). It has co-invested with Tekfen Ventures, Sucden Ventures and Rage Capital.

Type: Investor.
Portfolio on Recent Funding: 3.
Deals, last 12 months: 0.
Capital in their rounds: $117M.
Latest deal: Tropic Biosciences · Jul 6, 2022.

What Skyviews Life Science invests in

How Skyviews Life Science invests

StageDealsCapital in rounds
Series B+ 2 100%$117M
YearDealsCapital in rounds
2021 1 50%$82M
2022 1 50%$35M

Share is of the 2 rounds on Recent Funding that name Skyviews Life Science. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Skyviews Life Science portfolio companies

CompanyRound with Skyviews Life ScienceTotal raisedLatest raise
TTropic Biosciences
Commerce and retail
Series B+ · $35M$140MMar 12, 2026
Series B+
CCellares
Health and bio
Series B+ · $82M$357MJul 16, 2026
Series B+
OOne Bio
Health and bio
backer$27MDec 11, 2024
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Commerce and retail).

Portfolio companies are the companies on Recent Funding with a round that lists Skyviews Life Science, which is a subset of its real portfolio. API: /api/v1/investors/skyviews-life-science (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy